Actavis Recalls Drug Over Possibly Deadly Defect

Law360, New York (April 29, 2008, 12:00 AM EDT) -- Actavis Totowa LLC has instituted a nationwide recall of its prescription drug Digitek, saying that some tablets that were distributed are twice as potent as they should be.

Digitek is used to treat abnormal heart rhythms by reducing strain on the heart and helping it beat more strongly. Actavis Totowa, the U.S. division of Iceland-based pharmaceutical company Actavis Group, said in a statement that it has received “several” reports of people sickened by the defective tablets.

The company said the double-thickness tablets contain twice the appropriate...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.